Transmission Dynamics of Mpox in Peru During the 2022 Outbreak
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.24-0361 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von M Gabriela Soto-Cabezas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú. Hauptthemen laut MEDLINE: Disease Outbreaks, Mpox, Monkeypox. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In July 2022, mpox was declared an international public health emergency because of a surge in cases across Europe and America. This study assessed transmission dynamics and factors associated with hospitalization during the 2022 mpox outbreak in Peru. We performed a cross-sectional study using the Surveillance System of the National Center of Epidemiology, Prevention, and Disease Control (CDC-Peru) data. We estimated the basic reproduction number (R0), effective reproduction number (Rt), and the duration of the outbreak phases. We conducted mathematical modeling of the outbreak and estimated the serial interval. Additionally, we used Poisson regression with robust variance to identify hospitalization factors, using prevalence ratio. Between July and December 2022, 3,677 confirmed cases (96.3% male, mean age 32.6 years) were reported to the CDC-Peru. Of these, 75.0% were men who have sex with men (MSM), 55.6% had HIV infection, and 5.2% were hospitalized. The R0 was 2.37, with an exponential growth phase lasting 7 weeks, and Rt dropped to non-epidemic levels after 14 weeks. The incubation period and recovery period were estimated to be 6 days and 22 days, respectively. The serial interval was 9.3 days. HIV infection increased hospitalization risk. The 2022 mpox outbreak in Peru was characterized by primarily affecting a young MSM population, with a significant proportion being people living with HIV. Hospitalization was associated with HIV coinfection. This outbreak showed exponential growth during the first 7 weeks, followed by a marked deceleration of transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú.
- Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.
Zitieren
APA
Soto-Cabezas, M. G., Vásquez-Mejía, A., Calderón, M., Reyes-Vega, M., Blancas-Blas, Y. I., Soriano-Moreno, A. N., Vargas, M. A., Meza, K. R., Uchuya, J. R., Castro-Garro, D., Luque-Mamani, S., Espinoza-Hurtado, O. G. E., & Munayco, C. V. (2025). Transmission Dynamics of Mpox in Peru During the 2022 Outbreak. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0361
Vancouver
Soto-Cabezas MG, Vásquez-Mejía A, Calderón M, Reyes-Vega M, Blancas-Blas YI, Soriano-Moreno AN, et al. Transmission Dynamics of Mpox in Peru During the 2022 Outbreak. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.24-0361
BibTeX
@article{SotoCabezas2025,
author = {Soto-Cabezas, M Gabriela and Vásquez-Mejía, Adrián and Calderón, Martha and Reyes-Vega, Mary and Blancas-Blas, Yrene I and Soriano-Moreno, Anderson N and Vargas, María A and Meza, Kely R and Uchuya, Jorge R and Castro-Garro, Diego and Luque-Mamani, Sergio and Espinoza-Hurtado, Oswaldo G E and Munayco, Cesar V},
title = {Transmission Dynamics of Mpox in Peru During the 2022 Outbreak},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.24-0361}
}
EUVIMED